Authors:
Broxterman, HJ
Sonneveld, P
van Putten, WJL
Lankelma, J
Eekman, CA
Ossenkoppele, GJ
Pinedo, HM
Lowenberg, B
Schuurhuis, GJ
Citation: Hj. Broxterman et al., P-glycoprotein in primary acute myeloid leukemia and treatment outcome of idarubicin/cytosine arabinoside-based induction therapy, LEUKEMIA, 14(6), 2000, pp. 1018-1024
Authors:
Hooijberg, JH
Pinedo, HM
Vrasdonk, C
Priebe, W
Lankelma, J
Broxterman, HJ
Citation: Jh. Hooijberg et al., The effect of glutathione on the ATPase activity of MRP1 in its natural membranes, FEBS LETTER, 469(1), 2000, pp. 47-51
Citation: Pr. Wielinga et al., The relative importance of passive and P-glycoprotein mediated anthracycline efflux from multidrug-resistant cells, EUR J BIOCH, 267(3), 2000, pp. 649-657
Authors:
Jongsma, APM
Riethorst, A
Lankelma, J
Dekker, H
Westerhoff, HV
Citation: Apm. Jongsma et al., Evaluating limited specificity of drug pumps - Reduced relative resistancein human MDR phenotypes, EUR J BIOCH, 267(17), 2000, pp. 5369-5377
Authors:
Evers, R
de Haas, M
Sparidans, R
Beijnen, J
Wielinga, PR
Lankelma, J
Borst, P
Citation: R. Evers et al., Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export, BR J CANC, 83(3), 2000, pp. 375-383
Authors:
Broxterman, HJ
Sonneveld, P
Pieters, R
Lankelma, J
Eekman, CA
Loonen, AH
Schoester, M
Ossenkoppele, GJ
Lowenberg, B
Pinedo, HM
Schuurhuis, GJ
Citation: Hj. Broxterman et al., Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia, LEUKEMIA, 13(2), 1999, pp. 258-265
Authors:
Wielinga, PR
De Waal, E
Westerhoff, HV
Lankelma, J
Citation: Pr. Wielinga et al., In vitro transepithelial drug transport by on-line measurement: Cellular control of paracellular and transcellular transport, J PHARM SCI, 88(12), 1999, pp. 1340-1347